Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
Journal of Neuro-Oncology
|
May 22, 2015
Human chorionic gonadotropin is expressed virtually in all intracranial germ cell tumors
Hirokazu Takami, Shintaro Fukushima, Kohei Fukuoka, et al.
Acta Neuropathologica
|
January 7, 2017
Genome-wide DNA methylation profiling identifies primary central nervous system lymphoma as a distinct entity different from systemic diffuse large B-cell lymphoma
Taishi Nakamura, Satoshi Yamashita, Kazutaka Fukumura, et al.
International Journal of Clinical Oncology
|
November 11, 2024
Efficacy and safety of carmustine wafers, followed by radiation, temozolomide, and bevacizumab therapy, for newly diagnosed glioblastoma with maximal resection
Masayuki Kanamori, Ichiyo Shibahara, Yoshiteru Shimoda, et al.
Neuro-Oncology Advances
|
September 22, 2021
Low tumor cell content predicts favorable prognosis in germinoma patients
Hirokazu Takami, Kaishi Satomi, Kohei Fukuoka, et al.
Neuro-Oncology
|
February 9, 2022
Transcriptome and methylome analysis of CNS germ cell tumor finds its cell-of-origin in embryogenesis and reveals shared similarities with testicular counterparts
Hirokazu Takami, Asmaa Elzawahry, Yasin Mamatjan, et al.
Cancer Chemotherapy and Pharmacology
|
December 12, 2012
Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305)
Soichiro Shibui, Yoshitaka Narita, Junki Mizusawa, et al.
Journal of Neuro-Oncology
|
March 21, 2018
JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma
Toshihiko Wakabayashi, Atsushi Natsume, Junki Mizusawa, et al.
Journal of Neuro-Oncology
|
May 6, 2020
Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide alone
Atsushi Natsume, Kosuke Aoki, Fumiharu Ohka, et al.
Acta Neuropathologica
|
March 10, 2016
Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy
Koichi Ichimura, Shintaro Fukushima, Yasushi Totoki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 21, 2018
Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial
Takamasa Kayama, Shinya Sato, Kaori Sakurada, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
Journal of Neuro-Oncology
|
May 22, 2015
Human chorionic gonadotropin is expressed virtually in all intracranial germ cell tumors
Hirokazu Takami, Shintaro Fukushima, Kohei Fukuoka, et al.
Acta Neuropathologica
|
January 7, 2017
Genome-wide DNA methylation profiling identifies primary central nervous system lymphoma as a distinct entity different from systemic diffuse large B-cell lymphoma
Taishi Nakamura, Satoshi Yamashita, Kazutaka Fukumura, et al.
International Journal of Clinical Oncology
|
November 11, 2024
Efficacy and safety of carmustine wafers, followed by radiation, temozolomide, and bevacizumab therapy, for newly diagnosed glioblastoma with maximal resection
Masayuki Kanamori, Ichiyo Shibahara, Yoshiteru Shimoda, et al.
Neuro-Oncology Advances
|
September 22, 2021
Low tumor cell content predicts favorable prognosis in germinoma patients
Hirokazu Takami, Kaishi Satomi, Kohei Fukuoka, et al.
Neuro-Oncology
|
February 9, 2022
Transcriptome and methylome analysis of CNS germ cell tumor finds its cell-of-origin in embryogenesis and reveals shared similarities with testicular counterparts
Hirokazu Takami, Asmaa Elzawahry, Yasin Mamatjan, et al.
Cancer Chemotherapy and Pharmacology
|
December 12, 2012
Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305)
Soichiro Shibui, Yoshitaka Narita, Junki Mizusawa, et al.
Journal of Neuro-Oncology
|
March 21, 2018
JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma
Toshihiko Wakabayashi, Atsushi Natsume, Junki Mizusawa, et al.
Journal of Neuro-Oncology
|
May 6, 2020
Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide alone
Atsushi Natsume, Kosuke Aoki, Fumiharu Ohka, et al.
Acta Neuropathologica
|
March 10, 2016
Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy
Koichi Ichimura, Shintaro Fukushima, Yasushi Totoki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 21, 2018
Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial
Takamasa Kayama, Shinya Sato, Kaori Sakurada, et al.
Page
of 10